Filed in archive
Diagnostics, Methodologies and Instrumentation
, Drugs, Vaccines and Therapeutics
, Genomics, Proteomics and Bioinformatics
by ruth on April 27, 2006
In a study of patients with breast and head&neck tumors, they observed that patients whose tumors made high levels of LOX were more likely to have cancers that spread and to die of the disease. Animal tests also revealed that in mice where LOX production was inhibited, the tumors in the animals were also less likely to spread. These data therefore suggest that blocking LOX in patients with hypoxic tumors has potential as a new cancer therapy.
A therapy that specifically treats tumors producing LOX would be particularly exciting given that these are often among the deadliest cancers. [The lead researcher] said trials in people could start as soon as three years from now.
Other experiments are also underway to determine the relationship between LOX-production and hypoxia in other types of tumors including lung and colon.
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/20906
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for Lysyl Oxidase: Potential Target For Cancer Therapy:
|
Rating: 9.00 out of 5 vote(s) cast.
|
Response from:
Oliver Slay
(03/07/09 10:01pm)
Response from:
alex
(11/21/09 11:28pm)
bbc are very slow to publish anything before they have grounded evidence
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
http://news.bbc.co.uk/2/hi/health/7813072.stm